Kazutoshi Takahashi

Kazutoshi Takahashi

Auto-generated profile, based on publicly available information

Kazutoshi Takahashi

Department of Life Science Frontiers, Center for iPS Cell Research and Application, Kyoto University; Kyoto, 606-8507, Japan

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2003 in Nature
Verified
Journal Article
Open access
PDF file
KTKazutoshi Takahashi
Kazutoshi Takahashi
KMKaoru Mitsui
Kaoru Mitsui
SYShinya Yamanaka
Shinya Yamanaka
Embryonic stem (ES) cells are pluripotent cells derived from early mammalian embryos1,2. Their immortality and rapid growth make them attractive sources for stem cell therapies3; however, they produce tumours (teratomas) when transplanted, which could preclude their therapeutic usage4. Why ES cells, which lack chromosomal abnormalities, possess tumour-like properties is largely unknown. Here we show that mouse ES cells specifically express a Ras-like gene, which we have named ERas. We show that human HRasp, which is a recognized pseudogene, does not contain reported base substitutions and instead encodes the human orthologue of ERas. This protein contains amino-acid residues identical to those present in active mutants of Ras5 and causes oncogenic transformation in NIH 3T3 cells. ERas interacts with phosphatidylinositol-3-OH kinase6 but not with Raf7,8. ERas-null ES cells maintain pluripotency but show significantly reduced growth and tumorigenicity, which are rescued by expression of ERas complementary DNA or by activated phosphatidylinositol-3-OH kinase. We conclude that the transforming oncogene ERas is important in the tumour-like growth properties of ES cells.

20 October 2021 in Molecular Therapy Nucleic Acids
Verified
Journal Article
Open access
RHRina Hashimoto
Rina Hashimoto
ASAyaka Sakamoto
Ayaka Sakamoto
SDSayaka Deguchi
Sayaka Deguchi
RYRenxing Yi
Renxing Yi
ESEmi Sano
Emi Sano
KTKazuo Takayama
Kazuo Takayama
It has been reported that many receptors and proteases are required for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Although angiotensin-converting enzyme 2 (ACE2) is the most important of these receptors, little is known about the contribution of other genes. In this study, we examined the roles of neuropilin-1, basigin, transmembrane serine proteases (TMPRSSs), and cathepsins (CTSs) in SARS-CoV-2 infection using the CRISPR interference system and ACE2-expressing human induced pluripotent stem (iPS) cells. Double knockdown of TMPRSS2 and cathepsin B (CTSB) reduced the viral load to 0.036% ± 0.021%. Consistently, the combination of the CTPB inhibitor CA-074 methyl ester and the TMPRSS2 inhibitor camostat reduced the viral load to 0.0078% ± 0.0057%. This result was confirmed using four SARS-CoV-2 variants (B.1.3, B.1.1.7, B.1.351, and B.1.1.248). The simultaneous use of these two drugs reduced viral load to less than 0.01% in both female and male iPS cells. These findings suggest that compounds targeting TMPRSS2 and CTSB exhibit highly efficient antiviral effects independent of gender and SARS-CoV-2 variant.

25 May 2021 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
KTKazutoshi Takahashi
Kazutoshi Takahashi
MNMichiko Nakamura
Michiko Nakamura
COChikako Okubo
Chikako Okubo
ZKZane Kliesmete
Zane Kliesmete
MOMari Ohnuki
Mari Ohnuki
SYShinya Yamanaka
Shinya Yamanaka
Human pluripotent stem cells (PSCs) express human endogenous retrovirus type-H (HERV-H), which exists as more than a thousand copies on the human genome and frequently produces chimeric transcripts as long-non-coding RNAs (lncRNAs) fused with downstream neighbor genes. Previous studies showed that HERV-H expression is required for the maintenance of PSC identity, and aberrant HERV-H expression attenuates neural differentiation potentials, however, little is known about the actual of function of HERV-H. In this study, we focused on ESRG, which is known as a PSC-related HERV-H-driven lncRNA. The global transcriptome data of various tissues and cell lines and quantitative expression analysis of PSCs showed that ESRG expression is much higher than other HERV-Hs and tightly silenced after differentiation. However, the loss of function by the complete excision of the entire ESRG gene body using a CRISPR/Cas9 platform revealed that ESRG is dispensable for the maintenance of the primed and naïve pluripotent states. The loss of ESRG hardly affected the global gene expression of PSCs or the differentiation potential toward trilineage. Differentiated cells derived from ESRG-deficient PSCs retained the potential to be reprogrammed into induced PSCs (iPSCs) by the forced expression of OCT3/4, SOX2, and KLF4. In conclusion, ESRG is dispensable for the maintenance and recapturing of human pluripotency.

25 April 2022 in iScience
Verified
Journal Article
Open access
MIMio Iwasaki
Mio Iwasaki
YKYuka Kawahara
Yuka Kawahara
COChikako Okubo
Chikako Okubo
TYTatsuya Yamakawa
Tatsuya Yamakawa
MNMichiko Nakamura
Michiko Nakamura
KTKazutoshi Takahashi
Kazutoshi Takahashi
The effects of transcription factors on the maintenance and differentiation of human-induced or embryonic pluripotent stem cells (iPSCs/ESCs) have been well studied. However, the importance of posttranscriptional regulatory mechanisms, which cause the quantitative dissociation of mRNA and protein expression, has not been explored in detail. Here, by combining transcriptome and proteome profiling, we identified 228 posttranscriptionally regulated genes with strict upregulation of the protein level in iPSCs/ESCs. Among them, we found 84 genes were vital for the survival of iPSCs and HDFs, including 20 genes that were specifically necessary for iPSC survival. These 20 proteins were upregulated only in iPSCs/ESCs and not in differentiated cells derived from the three germ layers. Although there are still unknown mechanisms that downregulate protein levels in HDFs, these results reveal that posttranscriptionally regulated genes have a crucial role in iPSC survival.

24 January 2022 in Cell Reports Methods
Verified
Journal Article
Open access
KTKazutoshi Takahashi
Kazutoshi Takahashi
COChikako Okubo
Chikako Okubo
MNMichiko Nakamura
Michiko Nakamura
MIMio Iwasaki
Mio Iwasaki
YKYuka Kawahara
Yuka Kawahara
SYShinya Yamanaka
Shinya Yamanaka
Xeno-free culture systems have expanded the clinical and industrial application of human pluripotent stem cells (PSCs). However, reproducibility issues, often arising from variability during passaging steps, remain. Here, we describe an improved method for the subculture of human PSCs. The revised method significantly enhances the viability of human PSCs by lowering DNA damage and apoptosis, resulting in more efficient and reproducible downstream applications such as gene editing and directed differentiation. Furthermore, the method does not alter PSC characteristics after long-term culture and attenuates the growth advantage of abnormal subpopulations. This robust passaging method minimizes experimental error and reduces the rate of PSCs failing quality control of human PSC research and application.

11 April 2025 in Science Advances
Verified
Journal Article
Open access
COChikako Okubo
Chikako Okubo
MNMichiko Nakamura
Michiko Nakamura
MSMasae Sato
Masae Sato
YSYuichi Shichino
Yuichi Shichino
MMMari Mito
Mari Mito
KTKazutoshi Takahashi
Kazutoshi Takahashi
Although pluripotent stem cell (PSC) properties, such as differentiation and infinite proliferation, have been well documented within the frameworks of transcription factor networks, epigenomes, and signal transduction, they remain unclear and fragmented. Directing attention toward translational regulation as a bridge between these events can yield additional insights into previously unexplained mechanisms. Our functional CRISPR interference screen–based approach revealed that EIF3D, a translation initiation factor, is crucial for maintaining primed pluripotency. Loss of EIF3D disrupted the balance of pluripotency-associated signaling pathways, thereby compromising primed pluripotency. Moreover, EIF3D ensured robust proliferation by controlling the translation of various p53 regulators, which maintain low p53 activity in the undifferentiated state. In this way, EIF3D-mediated translation contributes to tuning the homeostasis of the primed pluripotency networks, ensuring the maintenance of an undifferentiated state with high proliferative potential. This study provides further insights into the translation network in maintaining pluripotency.